Dow Up 0.51% Nasdaq Up 0.24%

Salix Pharmaceuticals Ltd. (SLXP)

-NasdaqGS
102.90 Up 2.47(2.46%) 4:00PM EST
|After Hours : 102.90 0.00 (0.00%) 5:00PM EST
Prev Close:100.43
Open:101.72
Bid:N/A
Ask:103.50 x 100
1y Target Est:113.19
Beta:0.8
Next Earnings Date:N/A
Day's Range:100.02 - 103.62
52wk Range:82.52 - 172.98
Volume:3,241,139
Avg Vol (3m):2,549,760
Market Cap:6.56B
P/E (ttm):N/A
EPS (ttm):-1.22
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SLXP

Comparison

Symbol% ChgMkt Cap
SLXPUp 2.46%6.56B
BAYRYUp 1.77%120.46B
GSKUp 0.04%111.55B
WCRX 0.00%N/A

Key Statistics

Forward P/E (1 yr):22.08
P/S (ttm):4.64
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.40
Quarterly EPS Est (Dec-14) :1.22
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):1.31

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs and medical devices to treat various gastrointestinal diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback